$AVDL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AVADEL PHARMACEUTICALS PLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AVADEL PHARMACEUTICALS PLC. Get notifications about new insider transactions in AVADEL PHARMACEUTICALS PLC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | MONTEITH DAVID | See Remarks | Option Exercise | A | 10.40 | 75,000 | 780,000 | 75,000 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | MONTEITH DAVID | See Remarks | Option Exercise | A | 14.35 | 35,000 | 502,250 | 35,000 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | MONTEITH DAVID | See Remarks | Option Exercise | A | 16.30 | 110,000 | 1,793,000 | 110,000 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | MONTEITH DAVID | See Remarks | Grant | A | 0.00 | 32,500 | 0 | 32,500 | 0 to 32.5 K |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Option Exercise | A | 14.54 | 117,449 | 1,707,708 | 117,449 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Option Exercise | A | 14.54 | 100,000 | 1,454,000 | 100,000 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Grant | A | 0.00 | 16,200 | 0 | 16,200 | 0 to 16.2 K |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Grant | A | 0.00 | 40,000 | 0 | 40,000 | 0 to 40 K |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Grant | A | 0.00 | 492,678 | 0 | 492,678 | 0 to 492.7 K |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | NAVARRE CHRISTOPHE | Director | Option Exercise | A | 21.67 | 54,026 | 1,170,743 | 54,026 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | NAVARRE CHRISTOPHE | Director | Option Exercise | A | 14.54 | 46,000 | 668,840 | 46,000 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | D'SILVA DHIREN | See Remarks | Option Exercise | A | 10.40 | 80,000 | 832,000 | 80,000 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | D'SILVA DHIREN | See Remarks | Option Exercise | A | 23.53 | 50,000 | 1,176,500 | 50,000 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | D'SILVA DHIREN | See Remarks | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | MACKE SCOTT A. | See Remarks | Option Exercise | A | 10.40 | 65,000 | 676,000 | 65,000 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | MACKE SCOTT A. | See Remarks | Option Exercise | A | 14.35 | 35,000 | 502,250 | 35,000 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | MACKE SCOTT A. | See Remarks | Option Exercise | A | 16.30 | 50,000 | 815,000 | 50,000 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | MACKE SCOTT A. | See Remarks | Option Exercise | A | 7.36 | 20,000 | 147,200 | 20,000 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | MACKE SCOTT A. | See Remarks | Option Exercise | A | 4.07 | 7,500 | 30,525 | 7,500 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | MACKE SCOTT A. | See Remarks | Grant | A | 0.00 | 52,000 | 0 | 52,000 | 0 to 52 K |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | KANAN MICHAEL F | See Remarks | Option Exercise | A | 10.40 | 100,000 | 1,040,000 | 100,000 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | KANAN MICHAEL F | See Remarks | Option Exercise | A | 16.21 | 100,000 | 1,621,000 | 100,000 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | KANAN MICHAEL F | See Remarks | Grant | A | 0.00 | 18,000 | 0 | 18,000 | 0 to 18 K |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | CERUTTI GUILLAUME | Director | Option Exercise | A | 21.67 | 25,000 | 541,750 | 25,000 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | CERUTTI GUILLAUME | Director | Option Exercise | A | 14.54 | 60,000 | 872,400 | 60,000 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | CERUTTI GUILLAUME | Director | Option Exercise | A | 6.14 | 45,000 | 276,300 | 45,000 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | CERUTTI GUILLAUME | Director | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | ANDERSON MICHAEL S | Chief Executive Off ... | Option Exercise | A | 10.40 | 200,000 | 2,080,000 | 200,000 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | ANDERSON MICHAEL S | Chief Executive Off ... | Option Exercise | A | 14.35 | 200,000 | 2,870,000 | 200,000 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | ANDERSON MICHAEL S | Chief Executive Off ... | Option Exercise | A | 16.30 | 200,000 | 3,260,000 | 200,000 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | ANDERSON MICHAEL S | Chief Executive Off ... | Option Exercise | A | 4.07 | 80,500 | 327,635 | 80,500 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | ANDERSON MICHAEL S | Chief Executive Off ... | Option Exercise | A | 6.93 | 275,000 | 1,905,750 | 275,000 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | ANDERSON MICHAEL S | Chief Executive Off ... | Grant | A | 0.00 | 223,250 | 0 | 223,250 | 0 to 223.3 K |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | Hatten Sandra L | See Remarks | Option Exercise | D | 10.40 | 80,000 | 832,000 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | Hatten Sandra L | See Remarks | Option Exercise | D | 14.35 | 50,000 | 717,500 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | Hatten Sandra L | See Remarks | Option Exercise | D | 21.67 | 100,000 | 2,167,000 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | Hatten Sandra L | See Remarks | Sell | D | 0.00 | 33,000 | 0 | 0 | 33 K to 0 (-100.00 %) |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | GUSKY DAVID P | See Remarks | Option Exercise | D | 10.40 | 14,000 | 145,600 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | GUSKY DAVID P | See Remarks | Option Exercise | D | 7.85 | 50,000 | 392,500 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | GUSKY DAVID P | See Remarks | Sell | D | 0.00 | 2,000 | 0 | 0 | 2 K to 0 (-100.00 %) |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | MACKE SCOTT A. | See Remarks | Option Exercise | D | 10.40 | 65,000 | 676,000 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | MACKE SCOTT A. | See Remarks | Option Exercise | D | 14.35 | 35,000 | 502,250 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | MACKE SCOTT A. | See Remarks | Option Exercise | D | 16.30 | 50,000 | 815,000 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | MACKE SCOTT A. | See Remarks | Option Exercise | D | 7.36 | 20,000 | 147,200 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | MACKE SCOTT A. | See Remarks | Option Exercise | D | 4.07 | 7,500 | 30,525 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | MACKE SCOTT A. | See Remarks | Sell | D | 0.00 | 52,000 | 0 | 0 | 52 K to 0 (-100.00 %) |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | DAVIS GREGORY J. | See Remarks | Option Exercise | D | 10.40 | 65,000 | 676,000 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | DAVIS GREGORY J. | See Remarks | Option Exercise | D | 14.35 | 50,000 | 717,500 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | DAVIS GREGORY J. | See Remarks | Option Exercise | D | 21.67 | 50,000 | 1,083,500 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | DAVIS GREGORY J. | See Remarks | Sell | D | 0.00 | 30,000 | 0 | 0 | 30 K to 0 (-100.00 %) |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | SULLIVAN STEPHEN G. | See Remarks | Option Exercise | D | 10.40 | 65,000 | 676,000 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | SULLIVAN STEPHEN G. | See Remarks | Option Exercise | D | 23.53 | 50,000 | 1,176,500 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | SULLIVAN STEPHEN G. | See Remarks | Sell | D | 0.00 | 10,000 | 0 | 0 | 10 K to 0 (-100.00 %) |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | VAN ASSCHE BENOIT | Director | Option Exercise | D | 21.67 | 54,026 | 1,170,743 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | VAN ASSCHE BENOIT | Director | Option Exercise | D | 14.54 | 46,000 | 668,840 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | THOMPSON PHILLANDAS T. | See Remarks | Option Exercise | D | 10.40 | 100,000 | 1,040,000 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | THOMPSON PHILLANDAS T. | See Remarks | Option Exercise | D | 14.35 | 100,000 | 1,435,000 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | THOMPSON PHILLANDAS T. | See Remarks | Option Exercise | D | 16.30 | 95,000 | 1,548,500 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | THOMPSON PHILLANDAS T. | See Remarks | Option Exercise | D | 7.36 | 100,000 | 736,000 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | THOMPSON PHILLANDAS T. | See Remarks | Sell | D | 0.00 | 58,000 | 0 | 0 | 58 K to 0 (-100.00 %) |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | ANDERSON MICHAEL S | Chief Executive Off ... | Option Exercise | D | 10.40 | 200,000 | 2,080,000 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | ANDERSON MICHAEL S | Chief Executive Off ... | Option Exercise | D | 14.35 | 200,000 | 2,870,000 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | ANDERSON MICHAEL S | Chief Executive Off ... | Option Exercise | D | 16.30 | 200,000 | 3,260,000 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | ANDERSON MICHAEL S | Chief Executive Off ... | Option Exercise | D | 4.07 | 80,500 | 327,635 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | ANDERSON MICHAEL S | Chief Executive Off ... | Option Exercise | D | 6.93 | 275,000 | 1,905,750 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | ANDERSON MICHAEL S | Chief Executive Off ... | Sell | D | 0.00 | 223,250 | 0 | 0 | 223.3 K to 0 (-100.00 %) |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Option Exercise | D | 14.54 | 117,449 | 1,707,708 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Option Exercise | D | 14.54 | 100,000 | 1,454,000 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Sell | D | 0.00 | 16,200 | 0 | 0 | 16.2 K to 0 (-100.00 %) |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Sell | D | 0.00 | 40,000 | 0 | 0 | 40 K to 0 (-100.00 %) |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | STAPLETON CRAIG R | Director | Sell | D | 0.00 | 492,678 | 0 | 0 | 492.7 K to 0 (-100.00 %) |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | MONTEITH DAVID | See Remarks | Option Exercise | D | 10.40 | 75,000 | 780,000 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | MONTEITH DAVID | See Remarks | Option Exercise | D | 14.35 | 35,000 | 502,250 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | MONTEITH DAVID | See Remarks | Option Exercise | D | 16.30 | 110,000 | 1,793,000 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | MONTEITH DAVID | See Remarks | Sell | D | 0.00 | 32,500 | 0 | 0 | 32.5 K to 0 (-100.00 %) |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | FILDES FRANCIS | Director | Option Exercise | D | 21.67 | 54,026 | 1,170,743 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | FILDES FRANCIS | Director | Option Exercise | D | 14.54 | 46,000 | 668,840 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | FILDES FRANCIS | Director | Sell | D | 0.00 | 15,000 | 0 | 0 | 15 K to 0 (-100.00 %) |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | D'SILVA DHIREN | See Remarks | Option Exercise | D | 10.40 | 80,000 | 832,000 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | D'SILVA DHIREN | See Remarks | Option Exercise | D | 23.53 | 50,000 | 1,176,500 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | D'SILVA DHIREN | See Remarks | Sell | D | 0.00 | 15,000 | 0 | 0 | 15 K to 0 (-100.00 %) |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | CERUTTI GUILLAUME | Director | Option Exercise | D | 21.67 | 25,000 | 541,750 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | CERUTTI GUILLAUME | Director | Option Exercise | D | 14.54 | 60,000 | 872,400 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | CERUTTI GUILLAUME | Director | Option Exercise | D | 6.14 | 45,000 | 276,300 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | CERUTTI GUILLAUME | Director | Sell | D | 0.00 | 50,000 | 0 | 0 | 50 K to 0 (-100.00 %) |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | NAVARRE CHRISTOPHE | Director | Option Exercise | D | 21.67 | 54,026 | 1,170,743 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | NAVARRE CHRISTOPHE | Director | Option Exercise | D | 14.54 | 46,000 | 668,840 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | KANAN MICHAEL F | See Remarks | Option Exercise | D | 10.40 | 100,000 | 1,040,000 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | KANAN MICHAEL F | See Remarks | Option Exercise | D | 16.21 | 100,000 | 1,621,000 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | KANAN MICHAEL F | See Remarks | Sell | D | 0.00 | 18,000 | 0 | 0 | 18 K to 0 (-100.00 %) |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | Elrod Marcus W | See Remarks | Option Exercise | D | 10.40 | 22,000 | 228,800 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | Elrod Marcus W | See Remarks | Option Exercise | D | 13.59 | 100,000 | 1,359,000 | 0 | |
Jan 03 2017 | FLML | AVADEL PHARMACEUTI ... | Elrod Marcus W | See Remarks | Sell | D | 0.00 | 3,400 | 0 | 0 | 3.4 K to 0 (-100.00 %) |
Dec 20 2016 | FLML | FLAMEL TECHNOLOGIE ... | STAPLETON CRAIG R | Director | Gift | G | 0.00 | 16,200 | 0 | 16,200 | 0 to 16.2 K |
Dec 20 2016 | FLML | FLAMEL TECHNOLOGIE ... | STAPLETON CRAIG R | Director | Gift | G | 0.00 | 13,500 | 0 | 40,000 | 26.5 K to 40 K (+50.94 %) |
Dec 20 2016 | FLML | FLAMEL TECHNOLOGIE ... | STAPLETON CRAIG R | Director | Gift | G | 0.00 | 8,100 | 0 | 26,500 | 34.6 K to 26.5 K (-23.41 %) |
Dec 20 2016 | FLML | FLAMEL TECHNOLOGIE ... | STAPLETON CRAIG R | Director | Gift | G | 0.00 | 5,400 | 0 | 34,600 | 40 K to 34.6 K (-13.50 %) |
Dec 20 2016 | FLML | FLAMEL TECHNOLOGIE ... | STAPLETON CRAIG R | Director | Gift | G | 0.00 | 13,500 | 0 | 492,678 | 506.2 K to 492.7 K (-2.67 %) |
Dec 20 2016 | FLML | FLAMEL TECHNOLOGIE ... | STAPLETON CRAIG R | Director | Gift | G | 0.00 | 8,100 | 0 | 506,178 | 514.3 K to 506.2 K (-1.58 %) |
Dec 20 2016 | FLML | FLAMEL TECHNOLOGIE ... | STAPLETON CRAIG R | Director | Gift | G | 0.00 | 5,400 | 0 | 514,278 | 519.7 K to 514.3 K (-1.04 %) |
Dec 16 2016 | FLML | FLAMEL TECHNOLOGIE ... | GUSKY DAVID P | See Remarks | Option Exercise | A | 10.40 | 14,000 | 145,600 | 14,000 | |
Dec 16 2016 | FLML | FLAMEL TECHNOLOGIE ... | GUSKY DAVID P | See Remarks | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
Dec 16 2016 | FLML | FLAMEL TECHNOLOGIE ... | ANDERSON MICHAEL S | See Remarks | Option Exercise | A | 10.40 | 100,000 | 1,040,000 | 100,000 | |
Dec 16 2016 | FLML | FLAMEL TECHNOLOGIE ... | ANDERSON MICHAEL S | See Remarks | Grant | A | 0.00 | 18,000 | 0 | 58,000 | 40 K to 58 K (+45.00 %) |
Dec 16 2016 | FLML | FLAMEL TECHNOLOGIE ... | DAVIS GREGORY J. | See Remarks | Option Exercise | A | 10.40 | 100,000 | 1,040,000 | 100,000 | |
Dec 16 2016 | FLML | FLAMEL TECHNOLOGIE ... | DAVIS GREGORY J. | See Remarks | Grant | A | 0.00 | 18,000 | 0 | 58,000 | 40 K to 58 K (+45.00 %) |
Dec 16 2016 | FLML | FLAMEL TECHNOLOGIE ... | D'SILVA DHIREN | See Remarks | Option Exercise | A | 10.40 | 100,000 | 1,040,000 | 100,000 | |
Dec 16 2016 | FLML | FLAMEL TECHNOLOGIE ... | D'SILVA DHIREN | See Remarks | Grant | A | 0.00 | 18,000 | 0 | 58,000 | 40 K to 58 K (+45.00 %) |
Dec 16 2016 | FLML | FLAMEL TECHNOLOGIE ... | Elrod Marcus W | See Remarks | Option Exercise | A | 10.40 | 100,000 | 1,040,000 | 100,000 | |
Dec 16 2016 | FLML | FLAMEL TECHNOLOGIE ... | Elrod Marcus W | See Remarks | Grant | A | 0.00 | 18,000 | 0 | 58,000 | 40 K to 58 K (+45.00 %) |
Dec 16 2016 | FLML | FLAMEL TECHNOLOGIE ... | Hatten Sandra L | See Remarks | Option Exercise | A | 10.40 | 100,000 | 1,040,000 | 100,000 | |
Dec 16 2016 | FLML | FLAMEL TECHNOLOGIE ... | Hatten Sandra L | See Remarks | Grant | A | 0.00 | 18,000 | 0 | 58,000 | 40 K to 58 K (+45.00 %) |
Dec 16 2016 | FLML | FLAMEL TECHNOLOGIE ... | KANAN MICHAEL F | See Remarks | Option Exercise | A | 10.40 | 100,000 | 1,040,000 | 100,000 | |
Dec 16 2016 | FLML | FLAMEL TECHNOLOGIE ... | KANAN MICHAEL F | See Remarks | Grant | A | 0.00 | 18,000 | 0 | 58,000 | 40 K to 58 K (+45.00 %) |
Dec 16 2016 | FLML | FLAMEL TECHNOLOGIE ... | MACKE SCOTT A. | See Remarks | Option Exercise | A | 10.40 | 100,000 | 1,040,000 | 100,000 | |
Dec 16 2016 | FLML | FLAMEL TECHNOLOGIE ... | MACKE SCOTT A. | See Remarks | Grant | A | 0.00 | 18,000 | 0 | 58,000 | 40 K to 58 K (+45.00 %) |
Dec 16 2016 | FLML | FLAMEL TECHNOLOGIE ... | MONTEITH DAVID | See Remarks | Option Exercise | A | 10.40 | 100,000 | 1,040,000 | 100,000 | |
Dec 16 2016 | FLML | FLAMEL TECHNOLOGIE ... | MONTEITH DAVID | See Remarks | Grant | A | 0.00 | 18,000 | 0 | 58,000 | 40 K to 58 K (+45.00 %) |
Dec 16 2016 | FLML | FLAMEL TECHNOLOGIE ... | SULLIVAN STEPHEN G. | See Remarks | Option Exercise | A | 10.40 | 100,000 | 1,040,000 | 100,000 | |
Dec 16 2016 | FLML | FLAMEL TECHNOLOGIE ... | SULLIVAN STEPHEN G. | See Remarks | Grant | A | 0.00 | 18,000 | 0 | 58,000 | 40 K to 58 K (+45.00 %) |
Dec 16 2016 | FLML | FLAMEL TECHNOLOGIE ... | THOMPSON PHILLANDAS T. | See Remarks | Option Exercise | A | 10.40 | 100,000 | 1,040,000 | 100,000 | |
Dec 16 2016 | FLML | FLAMEL TECHNOLOGIE ... | THOMPSON PHILLANDAS T. | See Remarks | Grant | A | 0.00 | 18,000 | 0 | 58,000 | 40 K to 58 K (+45.00 %) |
Nov 30 2016 | FLML | FLAMEL TECHNOLOGIE ... | STAPLETON CRAIG R | Director | Buy | P | 10.85 | 10,000 | 108,500 | 40,000 | 30 K to 40 K (+33.33 %) |
Nov 30 2016 | FLML | FLAMEL TECHNOLOGIE ... | STAPLETON CRAIG R | Director | Buy | P | 10.74 | 10,000 | 107,370 | 30,000 | 20 K to 30 K (+50.00 %) |
Nov 22 2016 | FLML | FLAMEL TECHNOLOGIE ... | ANDERSON MICHAEL S | Chief Executive Off ... | Buy | P | 10.64 | 2,000 | 21,274 | 193,250 | 191.3 K to 193.3 K (+1.05 %) |
Sep 23 2016 | FLML | FLAMEL TECHNOLOGIE ... | FILDES FRANCIS | Director | Sell | S | 13.45 | 15,000 | 201,750 | 15,000 | 30 K to 15 K (-50.00 %) |
Sep 07 2016 | FLML | FLAMEL TECHNOLOGIE ... | ANDERSON MICHAEL S | Chief Executive Off ... | Buy | P | 14.12 | 2,000 | 28,240 | 191,250 | 189.3 K to 191.3 K (+1.06 %) |
Sep 06 2016 | FLML | FLAMEL TECHNOLOGIE ... | STAPLETON CRAIG R | Director | Buy | P | 13.52 | 10,000 | 135,190 | 519,678 | 509.7 K to 519.7 K (+1.96 %) |
Aug 29 2016 | FLML | FLAMEL TECHNOLOGIE ... | STAPLETON CRAIG R | Director | Buy | P | 13.67 | 9,122 | 124,698 | 20,000 | 10.9 K to 20 K (+83.86 %) |
Aug 29 2016 | FLML | FLAMEL TECHNOLOGIE ... | STAPLETON CRAIG R | Director | Buy | P | 13.83 | 10,878 | 150,443 | 10,878 | 0 to 10.9 K |
Aug 22 2016 | FLML | FLAMEL TECHNOLOGIE ... | ANDERSON MICHAEL S | Chief Executive Off ... | Buy | P | 14.30 | 5,000 | 71,479 | 189,250 | 184.3 K to 189.3 K (+2.71 %) |
Aug 12 2016 | FLML | FLAMEL TECHNOLOGIE ... | THOMPSON PHILLANDAS T. | See Remarks | Grant | A | 0.00 | 20,000 | 0 | 40,000 | 20 K to 40 K (+100.00 %) |
Aug 12 2016 | FLML | FLAMEL TECHNOLOGIE ... | MONTEITH DAVID | See Remarks | Grant | A | 0.00 | 15,000 | 0 | 17,500 | 2.5 K to 17.5 K (+600.00 %) |
Aug 12 2016 | FLML | FLAMEL TECHNOLOGIE ... | MACKE SCOTT A. | See Remarks | Grant | A | 0.00 | 15,000 | 0 | 42,000 | 27 K to 42 K (+55.56 %) |
Aug 12 2016 | FLML | FLAMEL TECHNOLOGIE ... | Hatten Sandra L | See Remarks | Grant | A | 0.00 | 20,000 | 0 | 23,000 | 3 K to 23 K (+666.67 %) |
Aug 12 2016 | FLML | FLAMEL TECHNOLOGIE ... | DAVIS GREGORY J. | See Remarks | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
Aug 12 2016 | FLML | FLAMEL TECHNOLOGIE ... | ANDERSON MICHAEL S | Chief Executive Off ... | Grant | A | 0.00 | 50,000 | 0 | 184,250 | 134.3 K to 184.3 K (+37.24 %) |
May 16 2016 | FLML | FLAMEL TECHNOLOGIE ... | ANDERSON MICHAEL S | Chief Executive Off ... | Buy | P | 8.84 | 5,000 | 44,200 | 134,250 | 129.3 K to 134.3 K (+3.87 %) |
May 16 2016 | FLML | FLAMEL TECHNOLOGIE ... | STAPLETON CRAIG R | Director | Buy | P | 9.25 | 2,415 | 22,339 | 509,678 | 507.3 K to 509.7 K (+0.48 %) |
May 16 2016 | FLML | FLAMEL TECHNOLOGIE ... | STAPLETON CRAIG R | Director | Buy | P | 9.21 | 24,813 | 228,553 | 507,263 | 482.5 K to 507.3 K (+5.14 %) |
Mar 22 2016 | FLML | FLAMEL TECHNOLOGIE ... | THOMPSON PHILLANDAS T. | See Remarks | Buy | P | 11.10 | 10,000 | 111,030 | 20,000 | 10 K to 20 K (+100.00 %) |
Mar 21 2016 | FLML | FLAMEL TECHNOLOGIE ... | ANDERSON MICHAEL S | Chief Executive Off ... | Buy | P | 11.04 | 5,000 | 55,220 | 129,250 | 124.3 K to 129.3 K (+4.02 %) |
Mar 21 2016 | FLML | FLAMEL TECHNOLOGIE ... | Hatten Sandra L | Sr. VP, Quality & R ... | Buy | P | 11.01 | 3,000 | 33,030 | 3,000 | 0 to 3 K |
Mar 16 2016 | FLML | FLAMEL TECHNOLOGIE ... | STAPLETON CRAIG R | Director | Buy | P | 10.39 | 100,000 | 1,039,400 | 482,450 | 382.5 K to 482.5 K (+26.15 %) |
Mar 16 2016 | FLML | FLAMEL TECHNOLOGIE ... | ANDERSON MICHAEL S | Chief Executive Off ... | Buy | P | 9.74 | 10,000 | 97,350 | 124,250 | 114.3 K to 124.3 K (+8.75 %) |